Embecta Corp. (FRA:JX7)

Germany · Delayed Price · Currency is EUR

9.60

-0.05 (-0.52%)

At close: Dec 19, 2025

Revenue by Product

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2017 - 2019
Diabetes Care	1.12B	Log In	Log In	Log In	Log In	Upgrade
Diabetes Care Growth	0.21%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2017 - 2019
United States	607.20M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	0.96%	Log In	Log In	Log In	Log In	Upgrade
International	515.90M	Log In	Log In	Log In	Log In	Upgrade
International Growth	-0.67%	Log In	Log In	Log In	Log In	Upgrade